UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report Pursuant
to
Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported)
|
September
14, 2006
|
PRESSURE
BIOSCIENCES, INC.
|
(Exact
Name of Registrant as Specified in its Charter)
|
|
MASSACHUSETTS
|
(State
or Other Jurisdiction of
Incorporation)
|
0-21615
|
|
04-2652826
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
321
Manley Street, West Bridgewater, MA
|
|
02379
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(508)
580-1818
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
N/A
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
4.01 Changes
in Registrants Certifying Accountant.
(a)
Previous
Independent Registered Public Accounting Firm
On
September 14, 2006, the Audit Committee of the Board of Directors of Pressure
BioSciences, Inc. (the “Company”) terminated the appointment of Weinberg
& Co. (“Weinberg”) as the Company’s independent registered public accounting
firm.
Weinberg's
reports on the Company’s consolidated financial statements for the fiscal years
ended December 31, 2005 and 2004 did not contain any adverse
opinion or a disclaimer of opinion, nor were the reports qualified or modified
as to uncertainty, audit scope or accounting principle.
During
the Company’s fiscal years ended December 31, 2005 and 2004 and through the
date hereof, there were no disagreements with Weinberg on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure, which disagreements, if not resolved to the satisfaction
of Weinberg, would have caused it to make reference thereto in its reports
on the Company’s financial statements for such years.
During
the Company’s fiscal years ended December 31, 2005 and 2004 and
through the date hereof, there were no reportable events as described in Item
304(a)(1)(v) of Regulation S-K.
The
Company requested that Weinberg furnish it with a letter addressed to the
Securities and Exchange Commission stating whether or not it agrees with the
above statements. A copy of such letter, dated September 15, 2006, is filed
as
Exhibit 16.1 to this Form 8-K.
(b)
Engagement
of New Independent Registered Public Accounting Firm.
On September
14, 2006, the Audit Committee of the Board of Directors of the Company
engaged UHY LLP (“UHY”) to serve as the Company’s independent registered
public accounting firm.
During
the fiscal years ended December 31, 2005 and 2004 and through the
date hereof, neither the Company nor anyone on its behalf consulted
with UHY with respect to any matters or events, including any matters
or events set forth and described in Items 304(a)(2)(i) and (ii) of Regulation
S-K.
Item
9.01 Financial
Statements and Exhibits
(d) Exhibits
Exhibit
Number
|
Exhibit
Description
|
|
|
16.1
|
Letter
from Weinberg & Co. to the Securities and Exchange Commission dated
September 15, 2006
|
|
|
99.1
|
Press
Release dated September 20, 2006
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this Report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
Dated:
September 20, 2006 |
PRESSURE BIOSCIENCES,
INC. |
|
|
|
|
By: |
/s/
Richard T. Schumacher |
|
Richard
T. Schumacher, President and Chief |
|
Executive
Officer |
EXHIBIT
INDEX
Exhibit
Number
|
Exhibit
Description
|
|
|
16.1
|
Letter
from Weinberg & Co. to the Securities and Exchange Commission dated
September 15, 2006
|
|
|
99.1
|
Press
Release dated September 20, 2006
|